BIT

5.00%

1.9¢ biotron limited

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-993

First 993 Last

Share
Profile

Follow
Nutler.

209 Posts.

97

19/11/18

11:09

Post #: 36554851
Share

Originally posted by Asimpletonne: ↑

I get that someone would have that view,(waiting for the science ect) but at this is the game of speculation. Its always been the view at this end of the market that the smart people wait and see the science, results or confirmation of concept before entering. Others are trading or willing to take the extra risk and getting in early for a much bigger reward, doesn't make them smarter or dumber just different view on risk. The conversation should be a civil one and should simply be "i appreciate the view of others and i wish them well but I'm waiting to see some confirmation before entering. The reverse should also apply. Its also pretty obvious that some are venting anger at a loss position or the fact that they have missed out.
I had a price re entry of 11c where i felt it was over done and reasonably priced for the possibility of a partnership or bigger deal.
At the same time i cant help but trade the momentum.
I personally believe that even if the science is not as convincing as we would hope, it's simply too much for a bigger player to walk away from. Some of the bigger pharma companied would spend the Bit MC of an office lunch. I personally think a bigger partnership is likely to help BIT see this through to some stage where others will be convinced to take it on bit time.
So I see two phases here.
1. A partnership to see the early stage results through to something more attractive for the much bigger player.
2. Once this is achieved a total take over.
All in my opinion. so do your own research and understand your risk profile.

Expand

Also, I entered at 3c.
More happy than less happy to risk it for the biscuit.
Less happy to than more happy to read another Davisite post.

#bringbackTez1

BIT Price at posting: 21.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 46 more messages in this thread...

First 993 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$5.671K	298.4K

Buyers (Bids)

No.	Vol.	Price($)
3	512798	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1050263	5

View Market Depth

No.	Vol.	Price($)
3	512798	0.019
10	1774771	0.018
8	927388	0.017
12	3258350	0.016
7	865000	0.015

Price($)	Vol.	No.
0.020	1000263	4
0.021	555000	2
0.022	997769	4
0.023	1100772	2
0.024	153949	2

Last trade - 15.59pm 04/10/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-993

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-993

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News